Racial/Ethnic Gaps in Outcomes Larger for Infants Conceived by ART

WEDNESDAY, Oct. 19, 2022 (HealthDay News) -- Women who conceive by medically assisted reproduction (MAR) have larger racial/ethnic disparities in adverse birth outcomes, such as neonatal and fetal death, according to a study published online Oct. 19 in Pediatrics.
Sarka Lisonkova, M.D., Ph.D., from the University of British Columbia in Vancouver, Canada, and colleagues conducted a population-based retrospective cohort study using data on all 7,545,805 singleton births in the United States in 2016 to 2017. Differences in the association between maternal race/ethnicity and adverse birth outcomes, including neonatal and fetal death, preterm birth, and serious neonatal morbidity, were examined among women who conceived spontaneously and those who used MAR, including assisted reproduction technology (ART).
Overall, 1.3 percent of singletons were conceived with MAR. The researchers found that infants of non-Hispanic Black versus non-Hispanic White women had almost twofold higher neonatal mortality in the spontaneous conception group (adjusted rate ratio [ARR], 1.9) and more than fourfold higher neonatal mortality in the ART-conception group (ARR, 4.1). With respect to preterm birth (<34 weeks) and perinatal mortality, racial/ethnic disparities between Hispanic and non-Hispanic White women were significantly larger among those who conceived using MAR.
"Future research should focus on identifying vulnerable women using risk factor and treatment information in order to improve management and outcomes for this high-risk subpopulation," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Geographic-Level Disparities Reported in Meeting Physical Activity Guidelines
THURSDAY, Jan. 26, 2023 (HealthDay News) -- Geographic-level disparities are...
¿Tarda más en realizar las tareas? Podría ser señal de riesgo de demencia
MARTES, 2 de mayo de 2023 (HealthDay News) -- Se da por sentado que los adultos...
Interferon Alfa-2b Effective for Low-Grade Lymphomatoid Granulomatosis
WEDNESDAY, April 12, 2023 (HealthDay News) -- For low-grade lymphomatoid...
ACR Updates Guidelines for Peri-TJA Med Use in Rheumatic Disease
MONDAY, March 21, 2022 (HealthDay News) -- In a guideline summary issued by the...
